|
Under a new FDA rule, medical device manufacturers can add or
strengthen contraindications, warnings, precautions or adverse
reactions sections of labeling via a premarket application
supplement without prior FDA approval, when “such modifications are
based on newly acquired information and evidence of a causal
association between the product and a safety signal is present.”
|